Pregabalin · Topic directory
All Pregabalin topics
Explore our complete directory of 29 UK clinical guides on Pregabalin. Browse by category below to find plain-English, source-backed answers for every aspect of treatment.
Use this guide to
Important before you order
UK regulation
It can only be supplied lawfully against an appropriate prescription and after the required clinical, pharmacy and identity checks.
For you as the buyer
- 1Use accurate information
Give your real name, date of birth, address, health information, current medicines, allergies and prescriber details. Do not use another person’s account or prescription.
- 2Provide a valid prescription
At checkout, upload the requested prescription or use the available UK prescriber service. A basket or payment is not a prescription and does not guarantee supply.
- 3Co-operate with safety checks
Answer follow-up questions honestly. The prescriber or pharmacist may refuse, amend or delay an order if the medicine, strength, quantity or patient information is not appropriate.
- 4Use and store it safely
Take Pregabalin only as prescribed, do not share or resell it, and keep it away from other people. Ask a pharmacist before changing, stopping or combining it with other medicines or alcohol.
For the seller, prescriber and pharmacy
- 1Be properly authorised
An online medicine seller must be legally authorised. Buyers should check the seller on the MHRA register and check that any pharmacy is registered with the GPhC; online doctor services should be registered with the relevant regulator.
- 2Prescribe independently and clinically
A prescriber must assess the patient, their medical history, current medicines, risks and the suitability of the requested treatment. A seller must not treat a completed questionnaire or payment as automatic approval.
- 3Supply only against a prescription
The pharmacy must dispense the prescribed medicine, strength and quantity under the required pharmacist supervision and follow controlled-drug, record-keeping, labelling and storage rules.
- 4Protect the patient
The service must provide clear information, protect personal and prescription data, use secure delivery and have a route for questions, complaints, suspected problems and reporting adverse effects.
- 5Do not advertise unlawfully
Prescription-only medicines must not be advertised to the general public as products available for direct purchase. Any product information must be accurate, balanced and not misleading.
We may cancel or refund an order where a prescription is missing, unclear, invalid, inconsistent with the patient details, clinically unsuitable, or cannot be verified. Never buy Pregabalin from an unregistered website.
This is general information, not legal advice. Rules can differ across England, Wales, Scotland and Northern Ireland. Read the current NHS medicines information, MHRA online seller register, MHRA advertising guidance and GOV.UK controlled-drug guidance.
Start here
6 guidesFundamental guides covering what Pregabalin is, why it is prescribed, how it works, and what to expect when beginning treatment.
Main Pregabalin guide
Comprehensive overview of Pregabalin in the UK: approved uses, dosing principles, side effects, interactions, and safety warnings.
What is Pregabalin?
Plain-English explanation of Pregabalin, how it belongs to the gabapentinoid group, UK brand names, and safety boundaries.
What is Pregabalin used for?
Licensed NHS and specialist indications including neuropathic pain, focal epilepsy, and generalised anxiety disorder.
How does Pregabalin work?
Mechanism of action in the nervous system: modulating calcium channels and neurotransmitter release to calm overactive nerve signals.
Dosage and how to take it
Prescribed starting doses, titration schedules, taking capsules or liquid, missed doses, and the importance of clinical review.
How long does it take to work?
Realistic timelines for onset of therapeutic benefit across nerve pain, anxiety, and epilepsy, and what to do if results vary.
Safety and daily use
7 guidesEssential safety information covering common and serious side effects, dangerous substance interactions, driving laws, and overdose action.
Pregabalin side effects overview
Common effects such as dizziness, sleepiness, headaches, and weight changes, long-term safety, and managing day-to-day effects.
Serious side effects & urgent help
Recognizing emergency signs including respiratory depression, severe allergic reactions (anaphylaxis), mood changes, and when to call 999.
Drug & substance interactions
Important interactions with opioids, sedatives, benzodiazepines, antidepressants, and over-the-counter medicines.
Pregabalin and alcohol
How alcohol amplifies sedation, dizziness, impaired coordination, memory disruption, and central nervous system depression.
Pregabalin and opioids
The serious clinical dangers of combining gabapentinoids with opioids, respiratory depression warnings, and MHRA safety advice.
Driving and operating machinery
UK drug-driving laws, evaluating personal impairment, DVLA notification rules, and staying safe on the road.
Overdose symptoms and action
What happens if you take too much Pregabalin, overdose symptoms, when to go to A&E, and contacting NHS 111 or emergency services.
Stopping and dependence
2 guidesMedical guidance on physical dependence, tolerance, addiction risks, and the necessity of a gradual, doctor-supervised taper.
Withdrawal & stopping safely
Why you should never stop abruptly, common withdrawal symptoms, withdrawal timelines, and safe clinical tapering strategies.
Dependence, tolerance & addiction
Distinguishing physical dependence from addiction, recognizing tolerance and misuse, and accessing confidential UK support.
Conditions and comparisons
6 guidesCondition-specific guides reviewing clinical evidence, UK treatment pathways, and comparisons with alternative medications.
Neuropathic and nerve pain
Prescribing for peripheral and central neuropathic pain, diabetic neuropathy, post-herpetic neuralgia, and clinical limitations.
Generalised anxiety disorder (GAD)
How Pregabalin is used for chronic anxiety in the UK, clinical evidence, review timelines, and managing dependence risk.
Epilepsy and partial seizures
Add-on therapy for focal seizures with or without secondary generalisation, strict timing rules, and seizure safety.
Sciatica & radicular nerve pain
UK clinical evidence regarding Pregabalin for lumbar radiculopathy, NICE guidelines, limitations, and alternative pain pathways.
Fibromyalgia & widespread pain
Understanding fibromyalgia, why UK licensing and NICE guidelines differ from international practice, and holistic care options.
Pregabalin vs Gabapentin
Detailed comparison of potency, pharmacokinetics, bioavailability, dosing frequency, cost, and safely switching between them.
Special situations and products
5 guidesImportant guidance for vulnerable patient groups, renal impairment, pregnancy, older adults, and UK product formulations.
Pregnancy and breastfeeding
Safety evidence during pregnancy, birth defect risk data, breastfeeding safety, and why treatment must not be stopped suddenly.
Kidney disease & renal dosing
Why kidney clearance is critical for Pregabalin excretion, dose adjustments based on eGFR/creatinine clearance, and monitoring.
Older adults & fall prevention
Managing increased susceptibility to dizziness, unsteady gait, cognitive clouding, fall risks, and age-related kidney decline.
Children & young people
Why standard adult guidance cannot be used for pediatric patients, off-label specialist prescribing, and safety precautions.
UK brands, forms & strengths
Guide to UK formulations: Lyrica, Alzain, Axalid, generic capsules (25mg to 300mg), and oral liquid solutions.
Questions and transparency
3 guidesDirect answers to frequent questions, UK regulatory history as a Class C controlled drug, and clinical editorial sources.
Frequently asked questions
Clear answers to common questions about weight gain, taking doses with food, memory fog, drug screening, and routine adjustments.
Regulatory history & UK timeline
Timeline of Pregabalin development, generic availability, and reclassification as a Schedule 3 Controlled Drug in Great Britain in 2019.
Clinical sources & editorial policy
Sourced references from NHS, MHRA Drug Safety Updates, BNF, NICE guidelines, and our medical verification standard.